Lorna Rothery discussed the challenges associated with the safe transfusion and supply of blood with Dr Evan M. Bloch, focusing on where future efforts to reduce transfusion-transmitted infections should be directed.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
Prof Monica Di Luca, President, European Brain Council, highlights the importance of continuous prioritisation and attention to brain research during the COVID-19 pandemic.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Jacqueline Bowman-Busato, EU Policy Lead at the European Association for the Study of Obesity, explains why obesity in Europe is an urgent and relevant health priority for policymakers, NGOs, research funders, health professionals and the public.
Margaret Heffernan, Author of Uncharted, shares her thoughts about how AI, big data and forecasting might not be the solution to the coronavirus, and how society should really be preparing itself for more inevitable epidemics.
Chris Wakefield, Vice President, European Marketing & Product Development, GOJO Industries-Europe Ltd. explores the rise of presenteeism and how to mitigate its impact via good hand hygiene.
Katie Ballard, a trustee of the Noonan Syndrome Association, shares her story of son Benjamin after receiving a life-changing diagnosis of Noonan Syndrome and cardiomyopathy.
As AI solutions are increasingly adopted in the healthcare sector, Dr Khalid Alyafei – Chief Medical Informatics Officer at Sidra Medicine in Qatar – discusses the benefits and challenges.
